Why did ZIVOW stock fall 92% today?

The fall appears linked to extreme low liquidity and concentrated selling rather than a clear public earnings update. With only **3,000** shares traded, few orders can move the price. Check SEC filings and company notices for confirmation.

What is Meyka AI’s view on ZIVOW stock?

Meyka AI rates ZIVOW at **65.59 / 100**, Grade **B**, Suggestion: **HOLD**. The model flags liquidity risk and mixed fundamentals. Forecasts show wide upside scenarios but are not guarantees.

What are the short‑term price targets for ZIVOW stock?

Meyka AI's short targets show **monthly $0.19** and **quarterly $1.46**. Given the current **USD 0.044** price, those targets reflect model scenarios, not assured outcomes. Use strict risk controls.

Where can I verify official ZIVO Bioscience filings?

Confirm filings and announcements on the company site and exchange pages. Start with the company website [ZIVO Bioscience website](https://www.zivobioscience.com) and the NASDAQ listing page for ZIVOW.

US Stocks

ZIVO Bioscience (ZIVOW) -92.0% to $0.04 06 Jan 2026 closed: liquidity outlook

ByHuzaifa Zahoor January 7, 2026

The market closed with ZIVOW stock plunging 92.00% to $0.044 on NASDAQ in the United States on 06 Jan 2026. This collapse follows a previous close of $0.55 and occurred on unusually thin trading volume 3,000 shares. We flag liquidity stress and valuation gaps as primary drivers.